Welcome!

News Feed Item

The Worldwide Market for Molecular Diagnostics 6-month Update

NEW YORK, March 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Worldwide Market for Molecular Diagnostics 6-month Update
http://www.reportlinker.com/p02051943/The-Worldwide-Market-for-Molecular-Diagnostics-6-month-Update.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.

In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular diagnostics with an emphasis on the last six months of 2013: July – December. This report highlights trends and developments that portent the evolution of molecular tests and technologies. The ensemble of consumer demand, technological advances and market forces create a dynamic, energetic and fast-moving environment for new tests and companies.

Though focused on the developments of the last six months, coverage is substantial.

As part of its coverage, this report provides, current market size and forecasts for Molecular Diagnostic Segments, including:

-Microbiology
-Histology
-Blood Screening
-Prenatal
-Coagulation
-Inherited Diseases
-Tissue Typing
-Cancer Markers
-Pharmacodiagnostics
- CTCs

The report provides breakout of key market segments for molecular diagnostic markets in world regions, including developed nations and emerging nations.

In addition the following important trend information is also provided:

-Selected Sequencing-Based Innovations July-December 2013
-Selected Molecular Diagnostics Collaborations, July-December 2013
-Selected Molecular Diagnostics Licensing Agreements, July-December 2013
-Selected Molecular Diagnostics Distribution Agreements, July-December 2013
-Regulatory and Reimbursement Update
-Molecular Test Revenues of The Top Companies, 2012-2013

Market analysis in this report covers world markets for in vitro diagnostics, however the reader will find a bias toward the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. The information presented in this report is derived primarily from company reports and other publicly available information published by government, and medical organizations.
CHAPTER ONE: MARKET OVERVIEW
Background
Scope and Methodology
Size And Growth Of The Market, Worldwide
Regulatory and Reimbursement Update
Company Moves
Top Suppliers and Niche players
Test Services Continue to Expand

Point of View
CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC
Background
Cancer gets more personal
Pathogen sequencing
CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER
Background
Blood-based analyses
Circulating Tumor Cells
CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Background
CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Background
Coagulation Market Analysis
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
Background
Molecular Histology
Market Analysis
HPV Testing
CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
Overview
HIV/AIDS
Hepatitis
Sexually Transmitted Diseases
Hospital Acquired Infections
Respiratory Tract Infections

Tuberculosis
Blood Culture
Miscellaneous
Mass Spectrometry
CHAPTER EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING
Background
Blood Pathogen Screening
Blood Typing
CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING
Background
Blood Pathogen Screening
Blood Typing
CHAPTER TEN: The Market For Molecular Assays For Inherited Diseases
Market Analysis
CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant
Management
Market Analysis
CHAPTER TWELVE: The Market For Molecular Assays
In Prenatal And Neonatal Testing
Market Analysis
CHAPTER THIRTEEN: Forecast: An Eye For The Next Six Months
– January To June 2014
Market Analysis

List of Tables

CHAPTER ONE: MARKET OVERVIEW
Table 1-1: Exchange Rate Fluctuations, 2009-2013
Table 1-2: Worldwide Molecular Test Sales, 2012-2013, by Test Segment (Growth Rates in
Molecular Diagnostics Compared (Microbiology, Histology, Blood Screening, Prenatal,
Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)
Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
Table 1-4: Selected Advanced Test Innovations, July –December 2013
Table 1-5: Selected Company Purchases And Joint Ventures, July-December 2013
Table 1-6: Selected collaborations, July-December 2013
Table 1-7: Selected licensing agreements, July-December 2013
Table 1-8: Selected distribution agreements, July-December 2013
Table 1-9: Molecular Test Revenues of The Top Companies, 2012-2013
Table 1-9: Molecular Test Revenues of The Top Companies, 2012 Vs. 2013
Table 1-10: Selected Molecular Test Services, Sales 2012-2013
Table 1-11: Selected Molecular Test Services, July-December 2013

CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC
Table 2-1: Major Sequencing Platforms
Table 2-2: Selected Sequencing-Based Innovations July-December 2013
CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER
Table 3-1: Selected Innovation In Blood-Based Cancer Tests, July-December 2013
Table 3-2: Selected Non-Invasive Molecular Cancer Tests In Development, July-December 2013
Table 3-3: Selected Innovations In Circulating Tumor Cell Testing, July-December 2013
CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Table 4-1: Selected Innovations In Molecular Hematological Tests, July-December 2013
CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Table 5-1: Selected Tests For Coagulation And Cardiac Disease Molecular Markers July- December 2013
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
Table 6-1: Worldwide Molecular Histology/Cytology Sales, 2012-2013
Table 6-2: Selected Molecular Histology Innovations, July-December 2013
Table 6-3: Selected Innovations In Molecular Tissue Sample Preparation, July – December 2013
Table 6-4: Selected Innovations In HPV Testing, July –December 2013
CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
Table 7-1: Molecular Test Sales, Microbiolog/Virology, 2012-2013
Table 7-2: Selected Hepatitis Test Innovations, July-December 2013
Table 7-3: Selected Innovations In Molecular STD Testing, July-December 2013
Table 7-4: Selected Molecular HAI Test Innovations, July-December 2013
Table 7-5: Selected Respiratory Tract Test Innovations, July-December 2013
Table 7-6: Selected Microbiology Innovations, July-December 2013
CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES
Table 9-1: Selected Innovations In Molecular Tests For Inherited Diseases, July – December 2013
CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant Management
Table 11-1: Selected Innovations In Prenatal Testing, July-December 2013

To order this report: The Worldwide Market for Molecular Diagnostics 6-month Update
http://www.reportlinker.com/p02051943/The-Worldwide-Market-for-Molecular-Diagnostics-6-month-Update.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
SYS-CON Events announced today that Super Micro Computer, Inc., a global leader in compute, storage and networking technologies, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Supermicro (NASDAQ: SMCI), the leading innovator in high-performance, high-efficiency server technology, is a premier provider of advanced server Building Block Solutions® for Data Center, Cloud Computing, Enterprise IT, Hadoop/...
Multiple data types are pouring into IoT deployments. Data is coming in small packages as well as enormous files and data streams of many sizes. Widespread use of mobile devices adds to the total. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will look at the tools and environments that are being put to use in IoT deployments, as well as the team skills a modern enterprise IT shop needs to keep things running, get a handle on all this data, and deli...
This talk centers around how to automate best practices in a multi-/hybrid-cloud world based on our work with customers like GE, Discovery Communications and Fannie Mae. Today’s enterprises are reaping the benefits of cloud computing, but also discovering many risks and challenges. In the age of DevOps and the decentralization of IT, it’s easy to over-provision resources, forget that instances are running, or unintentionally expose vulnerabilities.
For financial firms, the cloud is going to increasingly become a crucial part of dealing with customers over the next five years and beyond, particularly with the growing use and acceptance of virtual currencies. There are new data storage paradigms on the horizon that will deliver secure solutions for storing and moving sensitive financial data around the world without touching terrestrial networks. In his session at 20th Cloud Expo, Cliff Beek, President of Cloud Constellation Corporation, w...
In order to meet the rapidly changing demands of today’s customers, companies are continually forced to redefine their business strategies in order to meet these needs, stay relevant and continue to see profitable growth. IoT deployment and development is integral in this transformation, and today businesses are increasingly seeing the value of investing their resources into IoT deployments. These technologies are able increase ROI through projects such as connecting supply chains or enabling sm...
In his opening keynote at 20th Cloud Expo, Michael Maximilien, Research Scientist, Architect, and Engineer at IBM, will motivate why realizing the full potential of the cloud and social data requires artificial intelligence. By mixing Cloud Foundry and the rich set of Watson services, IBM's Bluemix is the best cloud operating system for enterprises today, providing rapid development and deployment of applications that can take advantage of the rich catalog of Watson services to help drive insigh...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 20th Cloud Expo, Tom Eck, Industry Platforms CTO at IBM Cloud, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing developers ...
Most DevOps journeys involve several phases of maturity. Research shows that the inflection point where organizations begin to see maximum value is when they implement tight integration deploying their code to their infrastructure. Success at this level is the last barrier to at-will deployment. Storage, for instance, is more capable than where we read and write data. In his session at @DevOpsSummit at 20th Cloud Expo, Josh Atwell, a Developer Advocate for NetApp, will discuss the role and value...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
As enterprise cloud becomes the norm, businesses and government programs must address compounded regulatory compliance related to data privacy and information protection. The most recent, Controlled Unclassified Information and the EU’s GDPR have board level implications and companies still struggle with demonstrating due diligence. Developers and DevOps leaders, as part of the pre-planning process and the associated supply chain, could benefit from updating their code libraries and design by in...
SYS-CON Events announced today that EARP Integration will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. EARP Integration is a passionate software house. Since its inception in 2009 the company successfully delivers smart solutions for cities and factories that start their digital transformation. EARP provides bespoke solutions like, for example, advanced enterprise portals, business intelligence systems an...